Live Quote · NASDAQDMRAHealthcare· Biotechnology

Damora Therapeutics, Inc.

$23.22▼ 4.44%($-1.08)
MKT CAP $1.44BNEXT EARNINGS Mar 18, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
67
Valuation
20
Profitability
15
Growth
80
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMRA research report →

Analyst Price Target
$52.50+126.1% vs. today

Range $40 – $60

Analyst RatingBuy
3 Buy0 Hold0 Sell

Price Chart

+36.27% · this period
$34.14$25.23$16.31Nov 20May 26Nov 20
52-Week Range33% of range
Low
$15.76
Current
$23.22
High
$38.33